A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

Clinical trial NCT06968845 · RECRUITING

Trial details

NCT number: NCT06968845
Sponsor: Rein Therapeutics
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Idiopathic Pulmonary Fibrosis (IPF)

Start date: 2026-02-02
Primary completion: 2027-09-30
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.